Mankind Pharma board approves raising Rs 10,000 crore through NCDs
Mankind Pharma has approved raising Rs 10,000 crore through the issuance of non-convertible debentures (NCDs) and commercial papers on a private placement basis.
The board has also constituted and authorized the fund raising committee to take all necessary actions, including finalisation of the terms of issuance, allotment of NCDs and CPs and other related matters.
Any further intimation in this connection will be intimated in due course.
Mankind Pharma is one of the leading pharmaceutical companies in India, known for providing medications at affordable prices. Recently, the company made headlines for acquiring BSV from private equity firm Advent International, marking it their largest acquisition since being listed.
For the first quarter of the financial year 2024-25, the company reported a net profit of Rs 543 crore, up by 10% from Rs 494 crore posted in the last-year period.
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
By — Rohit Srivastava, Founder
Stock Trading
Market 103: Mastering Trends with RMI and Techno-Funda Insights
By — Rohit Srivastava, Founder
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
ROC Made Easy: Master Course for ROC Stock Indicator
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
RSI Made Easy: RSI Trading Course
By — Souradeep Dey,
